These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3042816)

  • 41. Methotrexate hepatotoxicity and the role of routine liver biopsy: a collective opinion.
    Sinclair RD; Rotstein H; Clemmens L; Prentice D; Rode J; Breen K
    Australas J Dermatol; 1995 Nov; 36(4):228-9. PubMed ID: 8593119
    [No Abstract]   [Full Text] [Related]  

  • 42. Psoriasis, methotrexate, and cirrhosis.
    JAMA; 1970 Apr; 212(2):314-5. PubMed ID: 5467236
    [No Abstract]   [Full Text] [Related]  

  • 43. Methotrexate for psoriasis.
    Rees RB; Bennett JH; Maibach HI; Arnold HL
    Arch Dermatol; 1967 Jan; 95(1):2-11. PubMed ID: 6066717
    [No Abstract]   [Full Text] [Related]  

  • 44. Liver biopsy in methotrexate-treated psoriatics-a re-evalution.
    Zachariae H; Grunnet E; Sogaard H
    Acta Derm Venereol; 1975; 55(4):291-6. PubMed ID: 52258
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Methotrexate therapy of psoriasis. Effect and side effects with particular reference to hepatic changes. A survey.
    Nyfors A
    Dan Med Bull; 1980 Apr; 27(2):74-96. PubMed ID: 7000451
    [No Abstract]   [Full Text] [Related]  

  • 46. Methotrexate therapy for psoriasis. Guideline revisions.
    Roenigk HH; Maibach HI; Weinstein GP
    Arch Dermatol; 1973 Jul; 108(1):35. PubMed ID: 4716739
    [No Abstract]   [Full Text] [Related]  

  • 47. Methotrexate hepatotoxicity in psoriasis. Consideration of liver biopsies at regular intervals.
    Robinson JK; Baughman RD; Auerbach R; Cimis RJ
    Arch Dermatol; 1980 Apr; 116(4):413-5. PubMed ID: 7369769
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Methotrexate revisited: effects of long-term treatment in psoriasis.
    Van Dooren-Greebe RJ; Kuijpers AL; Mulder J; De Boo T; Van de Kerkhof PC
    Br J Dermatol; 1994 Feb; 130(2):204-10. PubMed ID: 8123573
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Methotrexate hepatotoxicity in psoriasis--comparison of different dose regimens.
    Dahl MG; Gregory MM; Scheuer PJ
    Br Med J; 1972 Mar; 1(5801):654-6. PubMed ID: 5015292
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Methotrexate for psoriasis: 1981.
    Rees RB
    Cutis; 1981 Aug; 28(2):166-8. PubMed ID: 7285624
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cirrhosis following prolonged treatment of psoriasis with methotrexate orally.
    Robeson JA; Spenney J; Hirschowitz BI
    South Med J; 1972 Apr; 65(4):453-6. PubMed ID: 5028402
    [No Abstract]   [Full Text] [Related]  

  • 52. Detection of hepatotoxicity associated with methotrexate therapy for psoriasis.
    O'Connor GT; Olmstead EM; Zug K; Baughman RD; Beck JR; Dunn JL; Seal P; Lewandowski JF
    Arch Dermatol; 1989 Sep; 125(9):1209-17. PubMed ID: 2774596
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biomarkers for methotrexate-induced liver injury: urinary protein profiling of psoriasis patients.
    van Swelm RP; Laarakkers CM; Kooijmans-Otero M; de Jong EM; Masereeuw R; Russel FG
    Toxicol Lett; 2013 Aug; 221(3):219-24. PubMed ID: 23830989
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Experience with methotrexate in the management of psoriasis].
    Mazzi R
    Dermatologica; 1969; 139(4):298-300. PubMed ID: 5374668
    [No Abstract]   [Full Text] [Related]  

  • 55. Liver damage and methotrexate.
    Baker H
    Br Med J; 1971 Jun; 2(5764):776. PubMed ID: 5090795
    [No Abstract]   [Full Text] [Related]  

  • 56. [Dynamics of some indices of interstitial metabolism in patients with psoriasis during treatment with methotrexate].
    Smelov NS; Lashmanova AP; Nikitina LV; Fedorovskaia RF; Makashev TK
    Vestn Dermatol Venerol; 1975 Nov; (11):8-13. PubMed ID: 1220384
    [No Abstract]   [Full Text] [Related]  

  • 57. Assessing the preferences of patients with psoriasis. A quantitative, utility approach.
    Zug KA; Littenberg B; Baughman RD; Kneeland T; Nease RF; Sumner W; O'Connor GT; Jones R; Morrison E; Cimis R
    Arch Dermatol; 1995 May; 131(5):561-8. PubMed ID: 7741543
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of possible chronic hepatotoxicity from methotrexate for psoriasis.
    Weinstein GD; Cox JW; Suringa DW; Millard MM; Kalser M; Frost P
    Arch Dermatol; 1970 Dec; 102(6):613-8. PubMed ID: 5501902
    [No Abstract]   [Full Text] [Related]  

  • 59. Liver Illness and Psoriatic Patients.
    Fiore M; Leone S; Maraolo AE; Berti E; Damiani G
    Biomed Res Int; 2018; 2018():3140983. PubMed ID: 29546055
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Psoriasis-cytostatic treatment with amethopterin (methotrexate)].
    Rassner G
    Fortschr Med; 1973 Mar; 91(9):381-8. PubMed ID: 4695452
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.